About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Disruptive Science and Technology

Editor-in-Chief: Alan J. Russell, PhD

ISSN: 2163-310X • Published Quarterly • Online ISSN: 2163-3118

Current Volume: 1

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Manuscripts must be submitted using the following url: http://mc.manuscriptcentral.com/disrupt

    Please read all the instructions to authors before submitting.

    Language must conform to acceptable English usage and syntax. The contents must be clear, accurate, coherent, and logical. The Editors will also consider its originality, teaching value, and validity.

    Please refer to the Word Limit section of these instructions for guidance on manuscript types and length. Occasional exceptions to these limitations may be made at the discretion of the Editor-in-Chief. To facilitate a quick review of manuscripts, authors are encouraged to suggest names of three to five potential reviewers with complete contact information when the manuscript is submitted.


    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.



    The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.

    Manuscript Submission and Review

    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted. By submitting a paper to the Journal, the author (or authors) agrees to each of the above conditions. In addition, the author (or authors) explicitly assigns any copyrighted ownership he/she (or they) may have in such paper to the Journal.

    Please include a cover letter with your submission.  The letter should address the disruptive potential of your work as well as discus barriers to overcome.  Please also include suggestions of three to five experts qualified to review your paper.

    Manuscript Types and Word Limits

    Word limits on the various types of manuscript types are as follows:

    Original article:                        5,000 words; 350 word maximum for abstracts

    Review articles:                       5,000 words; 350 word maximum for abstract (if applicable)

    Commentaries:                      1,500 words; 150 word maximum for abstract (if applicable)

    Perspectives:                           5,000 words; 350 word maximum for abstract (if applicable)

    Letters to the Editor:               1,000 words

    Brief Communications:          3,000 words  (no abstract)

    Guest Editorials:                      750 words

    Preparation of Manuscripts

    Papers must be submitted via upload in a word processing format, preferably in Microsoft Word. Please do not include any figures and/or tables within the main text document. Tables should be submitted in individual Word files.  Figures should be supplied in separate files, be labeled clearly, and should be in TIFF or EPS formats. Please see the Illustrations section for further details on art submission.

    All text must be double-spaced, including body, footnotes, references, legends, and tables. The title page should carry the full paper title, followed by the authors’ names, highest-received academic degree, and where the work was performed.  Also include a short title (running head) with a maximum of 45 characters (including spaces). Please indicate the corresponding author on the title page.


    An abstract should accompany every original submission. Abstracts should appear on their own separate page. It should consist of factual information and not generalities (the problem investigated, the method used, the results obtained, and the conclusions reached). A brief Introduction, Materials and Methods, Results, Discussion, Disruptive Potential, Barriers to Overcome, Conclusions, Acknowledgments, Disclosure, and Reference sections should follow. At the conclusion of the references, the name and complete address of the corresponding author should appear.

    Please note that in addition to traditional sections within the paper, all Original Article and Brief Communication manuscripts must include the following sections:

    Disruptive Potential:  In this section the authors should provide a clear and concise explanation of why they believe the work is potentially disruptive.  It should explain why the work is game-changing and how it impacts science, technology, and society. These explanations should be provided with enough detail for the editorial board to determine if the work is sufficiently disruptive.  The Journal’s current working assumption is that Disruptive Science and Technology has all of the following features:

    • Disruptive science and technology benefits society
    • Society intuitively recognizes the game-changing nature of the new approach
    • Disruptive science and technology creates a foundation for products and services that open and create new markets or radically alters existing business models
    • Disruptive science and technology will be resisted by the people and entities that represent and benefit from the status quo

    Although much has been written about “disruptive innovation” and the business practices that can harness radical new ideas to change the course of history, Disruptive Science and Technology seeks to be the venue that has been designed to accelerate the pace at which enabling science and engineering are used to innovate disruptively.

    Barriers to be overcome:  In this section authors should describe and explain the assumptions that will have to come true before the work described can actually be disruptive in a market or in society.  What shifts in attitudes, infrastructures or technology would be necessary for its large-scale adoption?  The hurdles could be scientific, market-driven, or society-based.  This section will allow the reader to make a judgment as to how advanced the science and engineering is that is being described. The Journal does not seek to only publish advanced concepts that are close to the marketplace.  Rather, the Journal seeks to identify new science and engineering that, once a series of predictable barriers are overcome, will be the foundation of disruption in the future.  This section will be the place where the author describes those barriers and explains why it is reasonable to predict that they are surmountable. 

    Statistical Analysis 

    If a statistical analysis is performed, an explanation of how it was performed must be stated at the end of the section preceding results. Unusual or complex methods of analysis should be referenced.


    References in text should be numerical using superscripted numbers.  Text references must be supplied in sequence for all tables and figures.

    The references must be double-spaced and must be cited in the text in numerical order, not alphabetically. References to journal papers should include (1) Authors (first three, then et al), (2) article title, (3) journal name (as abbreviated in Medline), (4) year (5) volume number, and (6) inclusive page range, in that order.

              Journal Article Example

              Spies JB. MR-guided focused ultrasound: A potentially disruptive technology. 
              J Am
              Coll Radiol. 2010;7:315-316.

    Abbreviate journal names according to the style of Medline.

    References to books should include (1) author(s), (2) chapter title (if any), (3) editor (if any), (4) title of book, (5) city of publication, (6) publisher, (7) year, and (8) page range if chapter is used. Volume and edition numbers, and name of translator should be included when appropriate. The author is responsible for the accuracy and completeness of the references.

              Book Example:

              Christensen CM, Grossman, JH, Hwang J.  The Innovator's Prescription:
              A Disruptive Solution for Health Care.  New York, NY: McGraw-Hill, 2008.


    Please follow these guidelines for submitting figures:


    • Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes.
    • Line illustrations should be submitted at 600 dpi
    • Halftones and color should be submitted at a minimum of 300 dpi.
    • Save as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.
    • Color art must be saved as CYMK—not RGB. (NB: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
    • Black and white art must be submitted as grayscale—not RGB.

    Do NOT submit Bitmap or Excel files. When naming your figure and table files, please label them with the main author’s last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1; Smith.Table1.

    Reprinted Figures: Illustrations taken from other publications must be acknowledged by a complete credit line in the legend. The publisher’s letter of permission should be submitted to Disruptive Technology.

    Additional information about converting figure files:

    Converting Word or Excel files
    : Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • Files should be scanned at 100% size
    • 300 dpi
    • Final color mode: CMYK
    • Save file as: .tif or .eps

    If you need directions on how to convert a PowerPoint slide to acceptable format go to: www.liebertpub.com/MEDIA/pdf/ppconvert.pdf


    Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.

    Author Disclosure Statement

    Immediately following the Acknowledgments section, include a section entitled Author Disclosure Statement. This text must be part of your actual manuscript file.  In this portion of the paper, authors must disclose any real or potential commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.

    Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at www.icmje.org/index.html#conflicts for further guidance.  If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

    After Acceptance of a Submitted Manuscript

    For each paper that is accepted, we will require that the corresponding author submit either an audio or video (preferred) file describing the significance of the science and engineering behind their research. This audio/video will be published as Supplementary Information and will be linked in the published article.

    For the required audio/video describing the significant science behind the research, the author should answer the following questions in the audio or video file: 

    •         Why is my/our study unique?

    •         What makes my/our study disruptive?

    •         Why did I decide to embark on this research?

    •         Who will it benefit most from this disruptive advance in science?

    •         Where could it backfire?

    •         What does the future hold for this innovation?

    •         What do I/we want to accomplish with this study?

    For each figure provided in the paper, authors are strongly encouraged, but not required, to submit either audio and/or video content to correspond with the paper and each figure in the paper. The purpose of this type of content is to provide a unique forum whereby authors will be able to communicate directly with readers.

    Video File Submission Requirements

    The following audio/video formats are acceptable for submission:

    • Audio Video Interleave (avi)
    • Quicktime (mov)
    • Windows Media (wmv)
    • Animated GIF (gif)
    • MPEG files

    Submit a brief legend for each videoin a Word file. All videos should be submitted at the desired reproduction size and length of 3-5 minutes. Videos should be no more than 10 MB in size and no more than 5 minutes in length. Authors are responsible for editing video files for quality assurance, and are also responsible for the content of the video.

    Audio File Submission Requirements

    Authors are encouraged to record and submit audio files describing the imperative and innovative science behind each figure and why it is significant and disruptive.

    Audio Interviews

    Corresponding authors may be asked to conduct a simple taped interview with the Editorial Staff of Disruptive Science and Technology.  These interviews will be used to enhance the readers’ understanding of the presented research.

    Page Proofs

    An e-mail containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned promptly to the Publisher with the author’s approval and/or corrections.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.


    The Journal is published quarterly by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; E-mail: info@liebertpub.com; Website: www.liebertpub.com/dst 

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    Rejuvenation Research

    Rejuvenation Research

    Key explorations and cutting-edge advancements on the molecular and cellular mechanisms that may ultimately contribute to slowing or reversing the aging process.

    Tissue Engineering, Parts A, B, & C

    Tissue Engineering, Parts A, B, & C

    The preeminent, biomedical journal bringing together the principles of engineering and life sciences to advance the field with cutting-edge research and applications on all aspects of tissue growth and regeneration.

    Soft Robotics

    Soft Robotics

    A multidisciplinary, peer-reviewed journal dedicated to the science and engineering of soft materials in mobile machines.

Browse All Publications »